Compare · GPUS vs TMO
GPUS vs TMO
Side-by-side comparison of Hyperscale Data Inc. (GPUS) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- GPUS operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $211.18B, about 4845.9x GPUS ($43.6M).
- Over the past year, GPUS is down 83.7% and TMO is up 17.2% - TMO leads by 100.9 points.
- GPUS has been more active in the news (10 items in the past 4 weeks vs 3 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 0 for GPUS).
- Company
- Hyperscale Data Inc.
- Thermo Fisher Scientific Inc
- Price
- $0.13+0.64%
- $568.15-0.75%
- Market cap
- $43.6M
- $211.18B
- 1M return
- -32.48%
- +15.46%
- 1Y return
- -83.71%
- +17.16%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- AMEX
- NYSE
- IPO
- 1997
- News (4w)
- 10
- 3
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest GPUS
- Hyperscale Data Bitcoin Treasury Reaches 1,087 Bitcoin Worth Approximately $70.3 Million
- Hyperscale Data to Host Financial Guidance and Business Outlook Conference Call on August 4, 2026
- Hyperscale Data Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
- Hyperscale Data Begins Installation of Omnipresent Robotics OPR-R2 Robots at Michigan AI Facility
- Hyperscale Data Expects to Sign AI Data Center and Neocloud Services Agreement with California-Based AI Company at Michigan Data Center Campus
- Hyperscale Data Bitcoin Treasury Reaches 1,032 Bitcoin Worth Approximately $65.8 Million and Acquired 130 Bitcoin During the Week Ended July 12, 2026
- Hyperscale Data Surpasses 1,000 Bitcoin in Corporate Treasury
- Hyperscale Data Reaffirms 2026 Revenue Guidance of $180 Million to $200 Million and Plans to Hold a Stockholder Conference Call in the Third Quarter to Discuss Ault Capital Group Divestiture and Long-Term Growth Strategy
- Hyperscale Data Reports Approximately $111.4 Million of Bitcoin Treasury, Cash, Restricted Cash and Silver Holdings, Including Approximately 900 Bitcoin
Latest TMO
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports Second Quarter 2026 Results
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target